These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16556300)

  • 21. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
    Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
    J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse.
    Lammertink M; Löhrer F; Kaiser R; Hambrecht M; Pukrop R
    Acta Psychiatr Scand; 2001 Nov; 104(5):361-6. PubMed ID: 11722317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden.
    Cantor-Graae E; Nordström LG; McNeil TF
    Schizophr Res; 2001 Mar; 48(1):69-82. PubMed ID: 11278155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
    Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
    Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.
    Mauri MC; Di Pace C; Reggiori A; Paletta S; Colasanti A
    Asian J Psychiatr; 2017 Oct; 29():117-122. PubMed ID: 29061407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance abuse and the onset of schizophrenia.
    Hambrecht M; Häfner H
    Biol Psychiatry; 1996 Dec; 40(11):1155-63. PubMed ID: 8931919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.
    Lysaker P; Bell M; Beam-Goulet J; Milstein R
    J Nerv Ment Dis; 1994 Feb; 182(2):109-12. PubMed ID: 8308528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.
    Tekin Uludağ Y; Güleç G
    Noro Psikiyatr Ars; 2016 Mar; 53(1):4-11. PubMed ID: 28360758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.
    Poirier S; Legris G; Tremblay P; Michea R; Viau-Guay L; Mérette C; Bouchard RH; Maziade M; Roy MA
    Schizophr Res; 2010 May; 118(1-3):285-91. PubMed ID: 20096540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
    Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
    Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse.
    Di Paolo M; Calabrese A; Nosari G; Ciappolino V; Cirella L; Caldiroli A; Capuzzi E; Clerici M; Buoli M
    J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541067
    [No Abstract]   [Full Text] [Related]  

  • 40. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.